Home
NICE Guidance
Conditions and diseases
Gynaecological conditions
Cervical cancer
Explore
Register as a stakeholder
Show sections
1 new
and
0 updated
products since January 2017.
NICE Pathways - mapping our guidance
Lung cancer
Suspected cancer recognition and referral
Diagnostics guidance
Adjunctive colposcopy technologies for examination of the uterine cervix – DySIS and the Niris Imaging System
(DG4)
August 2012
Technology appraisal guidance
Guidance on the use of liquid-based cytology for cervical screening
(TA69)
October 2003
Topotecan for the treatment of recurrent and stage IVB cervical cancer
(TA183)
October 2009
Interventional procedures guidance
High dose rate brachytherapy for carcinoma of the cervix
(IPG160)
March 2006
Laparoscopic radical hysterectomy for early stage cervical cancer
(IPG338)
May 2010
Quality standards
Suspected cancer
(QS124)
June 2016
NICE
Guidelines
Suspected cancer: recognition and referral
(NG12)
June 2015
NICE
Medtech innovation briefings
The ZedScan as an adjunct to colposcopy in women with suspected cervical intra‑epithelial neoplasia
(MIB20)
February 2015
In development
Adjunctive colposcopy technologies for assessing suspected cervical abnormalities (update of DG4)
(GID-DG10013)
December 2017
Diagnostics guidance
Guidance
Resources
Local practice